Abiopharma

Convening of a special meeting for 9.7.26 – the company’s engagements in agreements regarding the club company, renewal of the employment terms of relatives, voting instrument

Dorman Products, Inc. Announces Private Offering of $450 Million Of Senior Notes Due 2034

Celcuity’s Gedatolisib Combination Regimens Doubled the Likelihood of Survival without Disease Progression or Death Compared to Alpelisib plus Fulvestrant in the PIK3CA Mutant Cohort of the Pivotal Phase 3 VIKTORIA-1 Trial in Patients with HR+/HER2- Advanced Breast Cancer

Triller Group Inc. Receives Nasdaq Exception To Regain Minimum Bid Price Compliance

Quantum Announces Equity Financing to Strengthen Balance Sheet and Support Growth

Trustee’s report to the holders of BONDS 1 for the period from June 19, 2025 until the date of this report, by Hermetic Trust (1975) Ltd.

Quantum Announces Preliminary Fiscal Fourth Quarter 2026 Financial Results

Morgan Stanley Expansion Capital Leads $33 Million Growth Financing For Subtle Medical

Stratasys Celebrates Grand Opening of Americas Headquarters in Minnesota

Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exon 21 L858R Lung Cancer